Literature DB >> 9134005

Alertness, cognition and morphine in patients with advanced cancer.

M Clemons1, C Regnard, T Appleton.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9134005     DOI: 10.1016/s0305-7372(96)90026-2

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN: 0305-7372            Impact factor:   12.111


× No keyword cloud information.
  6 in total

Review 1.  The cognitive effects of opioids in cancer: a systematic review.

Authors:  Geana Paula Kurita; Lena Lundorff; Cibele Andrucioli de Mattos Pimenta; Per Sjøgren
Journal:  Support Care Cancer       Date:  2008-09-02       Impact factor: 3.603

2.  Sleep and GABA levels in the oral part of rat pontine reticular formation are decreased by local and systemic administration of morphine.

Authors:  C J Watson; R Lydic; H A Baghdoyan
Journal:  Neuroscience       Date:  2006-10-19       Impact factor: 3.590

3.  [Oral controlled-release oxycodone for the treatment of chronic pain. Data from 4196 patients].

Authors:  J Gaertner; M Frank; B Bosse; R Sabatowski; F Elsner; T Giesecke; L Radbruch
Journal:  Schmerz       Date:  2006-02       Impact factor: 1.107

4.  Buprenorphine disrupts sleep and decreases adenosine concentrations in sleep-regulating brain regions of Sprague Dawley rat.

Authors:  Elizabeth A Gauthier; Sarah E Guzick; Chad M Brummett; Helen A Baghdoyan; Ralph Lydic
Journal:  Anesthesiology       Date:  2011-10       Impact factor: 7.892

5.  Subjective daytime sleepiness and daytime function in patients on stable methadone maintenance treatment: possible mechanisms.

Authors:  David Wang; Harry Teichtahl; Cathy Goodman; Olaf Drummer; Ronald R Grunstein; Ian Kronborg
Journal:  J Clin Sleep Med       Date:  2008-12-15       Impact factor: 4.062

Review 6.  Sleep abnormalities associated with alcohol, cannabis, cocaine, and opiate use: a comprehensive review.

Authors:  Gustavo A Angarita; Nazli Emadi; Sarah Hodges; Peter T Morgan
Journal:  Addict Sci Clin Pract       Date:  2016-04-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.